Sujet

Managing Director Dr. Ingmar Hoerr

Légende

Managing Director Dr. Ingmar Hoerr, CureVac GmbH in the Tuebingen-Reutlingen Technology Park, Biotechnology Start-up Centre, develops vaccine against coronavirus, COVID-19 pandemic, Stuttgart, Germany, Europe

Date

2020

Crédit

Photo12/imageBROKER/Martin Storz

Notre référence

BRK20A27_023

Model release

No

Property release

NA

Licence

Rights managed

Format disponible

50.0Mb (1.1Mb) / 16.1in x 12.1in / 4828 x 3621 (300dpi)

Mots clés

2 people CEO CEOs Central Europe Corona Coronavirus Covid-19 Europe German Federal Republic Germany Laboratory test Middle Europe No People Pandemic SARS-CoV-2 South Germany Southern Germany Stuttgart Sueddeutschland biotechnologies biotechnology building buildings chief executive officer cities city contagious contra danger of infection disease diseases epidemic health healthcare healthcare system infection infections infectious infective investigate lab laboratories laboratory laboratory analysis laboratory equipment laboratory equipments laboratory examination laboratory study manager medical medical care medical cares medical technology medicine no one nobody prevention preventions research facilities research facility risk of infection risks of infections science sciences scientific scientific research sera serum sickness symbolic symbolic image symbolic picture symbolic pictures technology park test tests two people vaccination vaccinations vaccine virulent virus viruses Baden-Wurttemberg Baden-Wuerttemberg building complex building complexes check epidemic plague epidemic plagues examination examinations examine examining inspect provincial capital provincial capitals scrutinise scrutinize threat threats